3 ms·
They're simply trying to eliminate most academic research, there aren't many other plausible explanations here. Blocking the grant reviews might look temporary,
by fabian2k 2y ago
They're simply trying to eliminate most academic research, there aren't many other plausible explanations here. Blocking the grant reviews might look temporary, but these delays pile up and at some point it simply won't be possible to properly review the grants in time.
And this is not the only way they're interfering with scientific research, the hard cap on indirect costs is probably the other most significant event. And all of this is on extremely short notice (or actually retroactive as it applies to grants that are already approved), which makes it even more destructive.
- readyplayernull 2y agoBigPharma and others will gladly take care of the research debt, and they'll be paid handsomely. They seem pretty enthusiastic about it: https://www.science.org/content/blog-post/pharma-ceos-speaking-damn-it https://www.science.org/content/blog-post/pharma-ceos-speaki...
- fabian2k 2y agoThe research done at universities and pharma companies is simply different and not interchangeable. This move will also kill the pipeline for new scientists that pharma companies want to hire. If you want to read a bit about all these event from the perspective of someone working in pharma I'd recommend Derek Lowe's blog: https://www.science.org/blogs/pipeline https://www.science.org/blogs/pipeline
- lightbendover 2y ago[dead]
- readyplayernull 2y agoI wish I was, but the trend is privatizing. Let's hear the beast talk by itself: https://www.science.org/content/blog-post/pharma-ceos-speaking-damn-it https://www.science.org/content/blog-post/pharma-ceos-speaki...